The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval. Key drivers include ...
Parkinson's disease (PD) is a neurodegenerative disorder of uncertain pathogenesis characterized by a loss of substantia nigra pars compacta (SNpc) dopaminergic (DA) neurons, and can be modeled by the ...
Xiao Wen Mao, Nina C. Nishiyama, Mary Campbell-Beachler, Peter Gifford, Kristine E. Haynes, Daila S. Gridley and Michael J. Pecaut The purpose of this study was to determine whether nicotinamide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback